CLINICAL_TRIALS
trial_result
· 2018-04-23
Clinical Trial Update: Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer [Phase 3]
Summary
Phase 3 trial results for Sativex (nabiximols) assessing relief of persistent pain in participants with advanced cancer, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GW Pharmaceuticals Ltd | Conditions: Pain, Advanced Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-04-23